CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-07 | BERTOLINI ROBERT J Director | Grant or award | +355 | 29,489 | ||
| 2021-05-07 | BERTOLINI ROBERT J Director | Grant or award | +248 | 29,737 | ||
| 2021-05-07 | BERTOLINI ROBERT J Director | Grant or award · Stock Options (Right to Buy) | +1,151 | 1,151 | ||
| 2021-05-07 | Andrews Nancy C Director | Grant or award | +355 | 1,220 | ||
| 2021-05-07 | Andrews Nancy C Director | Grant or award · Stock Options (Right to Buy) | +1,151 | 1,151 | ||
| 2021-05-07 | FOSTER JAMES C Chairman, President and CEO | Sale | −2,484 | $341.80 | $849K | 221,088 |
| 2021-05-07 | FOSTER JAMES C Chairman, President and CEO | Sale | −1,102 | $342.42 | $377K | 219,986 |
| 2021-05-07 | FOSTER JAMES C Chairman, President and CEO | Sale | −2,008 | $343.55 | $690K | 217,978 |
| 2021-05-07 | FOSTER JAMES C Chairman, President and CEO | Sale | −1,300 | $344.60 | $448K | 216,678 |
| 2021-05-07 | FOSTER JAMES C Chairman, President and CEO | Sale | −606 | $345.85 | $210K | 216,072 |
| 2021-05-06 | MASSARO GEORGE Director | Sale | −1,572 | $336.06 | $528K | 7,169 |
| 2021-05-06 | MASSARO GEORGE Director | Sale | −910 | $336.84 | $307K | 6,259 |
| 2021-05-06 | MASSARO GEORGE Director | Sale | −288 | $338.06 | $97K | 5,971 |
| 2021-05-06 | MASSARO GEORGE Director | Sale | −600 | $338.98 | $203K | 5,371 |
| 2021-05-04 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +3,305 | $144.67 | $478K | 18,167 |
| 2021-05-04 | Smith David Ross Corporate Executive VP & CFO | Sale | −3,305 | $340.01 | $1.1M | 14,862 |
| 2021-05-04 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −3,305 | 6,609 | ||
| 2021-05-01 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Shares withheld for taxes | −93 | $332.45 | $31K | 3,959 |
| 2021-04-22 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +3,845 | $109.34 | $420K | 18,707 |
| 2021-04-22 | Smith David Ross Corporate Executive VP & CFO | Sale | −3,845 | $330.00 | $1.3M | 14,862 |
Page 42 of 60 · 1,185 trades